中国中药杂志

2022, v.47(18) 5106-5112

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

气滞胃痛颗粒治疗功能性消化不良的系统评价与药物经济学研究
Systematic review and pharmacoeconomic evaluation of Qizhi Weitong Granules in treatment of functional dyspepsia

李科标;田杨;韩晟;林丽开;李薇;
LI Ke-biao;TIAN Yang;HAN Sheng;LIN Li-kai;LI Wei;Hospital Management Institute of Wuhan University;International Research Center for Medical Administration, Peking University;

摘要(Abstract):

该研究旨在评价气滞胃痛颗粒治疗功能性消化不良的有效性、安全性与经济性。选取临床常用的治疗功能性消化不良方案:气滞胃痛颗粒+莫沙必利片vs单用莫沙必利片,基于已发表的临床研究进行Meta分析,评价治疗的有效性、安全性,并以Meta分析结果作为效果进行药物经济学评价。采用成本-效果手段对增量成本-效果比(ICER)进行分析,并通过旋风图、蒙特卡洛模拟进行敏感性分析。通过调研功能性消化不良患者,确定该病的意愿支付阈值,并与ICER对比,从对气滞胃痛颗粒的经济性进行评价。基础分析结果显示,气滞胃痛颗粒+莫沙必利片治疗功能性消化不良有效率为95.49%,高于单用莫沙必利片(73.30%)(OR=8.52,95%CI[4.36,16.64]),具有显著性差异(P<0.000 1)。安全性方面,2组无显著性差异。气滞胃痛颗粒+莫沙必利片价格相较于单用莫沙必利片更高,ICER为640.29元,但低于患者意愿支付阈值1 506.67元,敏感性分析显示结果较为稳健。综上,气滞胃痛颗粒+莫沙必利片治疗功能性消化不良安全且更加有效、经济,临床值得推广。
This study aims to investigate the efficacy, safety, and cost-effecctiveness of Qizhi Weitong Granules in the treatment of functional dyspepsia. Specifically, two commonly used clinical protocols for the treatment of functional dyspepsia were selected: Qizhi Weitong Granules+Mosapride vs Mosapride alone(control). Meta-analysis of previous clinical studies was performed to examine the efficacy and safety, and pharmacoeconomic evaluation was carried out according to the results of the Meta-analysis. The cost-effectiveness analysis was carried out to elucidated the incremental cost-effectiveness ratio(ICER), and the sensitivity was analyzed with tornado dia-gram and Monte Carlo simulation. The willingness-to-pay threshold of patients for functional dyspepsia was investigated and compared with the ICER to evaluate whether Qizhi Weitong Granules was cost-effective. The result showed that the effective rate of Qizhi Weitong Granules combined with Mosapride in the treatment of functional dyspepsia was 95.49%, which was higher than that of Mosapride alone(73.30%)(OR=8.52, 95%CI[4.36, 16.64])(P<0.000 1). The two groups showed no significant difference in safety. The price of Qizhi Weitong Granules+Mosapride was higher than that of Mosapride alone. The ICER was 640.29 CNY, 1 506.67 CNY lower than the willingness-to-pay threshold. The sensitivity analysis showed that the analysis results were relatively stable. Thus, Qizhi Weitong Granules+Mosapride is safe, effective, and economical in the treatment of functional dyspepsia, which should be further promoted in clinical settings.

关键词(KeyWords): 气滞胃痛颗粒;功能性消化不良;成本-效果分析;Meta分析;决策树模型
Qizhi Weitong Granules;functional dyspepsia;cost-effectiveness analysis;Meta-analysis;decision tree model

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 李科标;田杨;韩晟;林丽开;李薇;
LI Ke-biao;TIAN Yang;HAN Sheng;LIN Li-kai;LI Wei;Hospital Management Institute of Wuhan University;International Research Center for Medical Administration, Peking University;

DOI: 10.19540/j.cnki.cjcmm.20220529.502

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享